Option Care Health, Inc. (NASDAQ:OPCH) Shares Acquired by HighTower Advisors LLC

HighTower Advisors LLC increased its position in Option Care Health, Inc. (NASDAQ:OPCH) by 16.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 468,082 shares of the company’s stock after buying an additional 67,021 shares during the period. HighTower Advisors LLC owned about 0.28% of Option Care Health worth $10,860,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. UMB Bank n.a. increased its position in Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after purchasing an additional 346 shares during the last quarter. Quarry LP increased its position in shares of Option Care Health by 327.7% in the third quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after acquiring an additional 2,628 shares in the last quarter. Blue Trust Inc. increased its position in shares of Option Care Health by 16.9% in the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock worth $109,000 after acquiring an additional 681 shares in the last quarter. Venturi Wealth Management LLC raised its stake in shares of Option Care Health by 2,621.3% in the 4th quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company’s stock valued at $110,000 after acquiring an additional 4,561 shares during the period. Finally, KBC Group NV raised its stake in shares of Option Care Health by 16.2% in the 3rd quarter. KBC Group NV now owns 5,013 shares of the company’s stock valued at $157,000 after acquiring an additional 700 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on OPCH. JMP Securities reissued a “market outperform” rating and issued a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. JPMorgan Chase & Co. raised their target price on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. Barrington Research raised their target price on shares of Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th. UBS Group began coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price on the stock. Finally, Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their target price for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $33.00.

Option Care Health Price Performance

OPCH opened at $32.66 on Monday. The firm has a market cap of $5.40 billion, a price-to-earnings ratio of 27.45, a PEG ratio of 2.30 and a beta of 1.33. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $34.85. The company has a fifty day simple moving average of $30.81 and a 200 day simple moving average of $28.21.

Insiders Place Their Bets

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares of the company’s stock, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.64% of the stock is owned by company insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.